87671420 - EVOLVE BIOLOGICS

Information

  • Trademark
  • 87671420
  • Serial Number
    87671420
  • Registration Number
    6297746
  • Filing Date
    November 03, 2017
    7 years ago
  • Registration Date
    March 23, 2021
    4 years ago
  • Transaction Date
    July 07, 2021
    4 years ago
  • Status Date
    March 23, 2021
    4 years ago
  • Published for Opposition Date
    January 05, 2021
    4 years ago
  • Location Date
    March 23, 2021
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MORENO, PAUL A
  • Attorney Docket Number
    7933.824US01
    Attorney Name
    Christopher J. Schulte
    Law Office Assigned Location Code
    L30
  • Owners
Mark Drawing Code
4000
Mark Identification
EVOLVE BIOLOGICS
Case File Statements
  • D10000: "BIOLOGICS"
  • GS0051: Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods
  • GS0371: Construction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities
  • GS0401: Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics
  • GS0411: Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment
  • GS0421: Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate
Case File Event Statements
  • 7/7/2021 - 4 years ago
    53 - REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED Type: CORV
  • 7/1/2021 - 4 years ago
    52 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 3/23/2021 - 4 years ago
    51 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/5/2021 - 4 years ago
    50 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/5/2021 - 4 years ago
    49 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/16/2020 - 4 years ago
    48 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/30/2020 - 4 years ago
    47 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 11/26/2020 - 4 years ago
    46 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/25/2020 - 4 years ago
    45 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/24/2020 - 4 years ago
    44 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/24/2020 - 4 years ago
    43 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/6/2020 - 5 years ago
    42 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/6/2020 - 5 years ago
    41 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/6/2020 - 5 years ago
    40 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/25/2020 - 5 years ago
    39 - LETTER OF PROTEST EVIDENCE FORWARDED Type: LOPT
  • 2/12/2020 - 5 years ago
    38 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/12/2020 - 5 years ago
    37 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/12/2020 - 5 years ago
    36 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/28/2020 - 5 years ago
    35 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 1/27/2020 - 5 years ago
    34 - WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST Type: PBSR
  • 1/14/2020 - 5 years ago
    33 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/14/2020 - 5 years ago
    32 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/14/2020 - 5 years ago
    31 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/10/2020 - 5 years ago
    30 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 1/1/2020 - 5 years ago
    29 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 11/27/2019 - 5 years ago
    28 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 11/19/2019 - 5 years ago
    27 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 11/19/2019 - 5 years ago
    26 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 11/19/2019 - 5 years ago
    25 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 11/18/2019 - 5 years ago
    24 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK
  • 10/30/2019 - 5 years ago
    23 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 5/18/2019 - 6 years ago
    22 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 5/18/2019 - 6 years ago
    21 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 5/18/2019 - 6 years ago
    20 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 5/16/2019 - 6 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/16/2019 - 6 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/9/2019 - 6 years ago
    17 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 11/14/2018 - 6 years ago
    16 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 11/14/2018 - 6 years ago
    15 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 11/14/2018 - 6 years ago
    14 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 5/9/2018 - 7 years ago
    13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 5/9/2018 - 7 years ago
    12 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 5/9/2018 - 7 years ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 5/9/2018 - 7 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/9/2018 - 7 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/2/2018 - 7 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 4/24/2018 - 7 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/16/2018 - 7 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/16/2018 - 7 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/16/2018 - 7 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/14/2018 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/14/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 11/7/2017 - 7 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP